Lactobacillus rhamnosus strain GG modulates intestinal absorption, fecal excretion, and toxicily of aflatoxin B1 in rats

Applied and Environmental Microbiology

Volumn 72, Issue 11, 2006, Pages 7398-7400

  Gratz, S ^a   Taubel M ^a   Juvonen, R O ^a   Viluksela, M ^b   Turner, P C ^c   Mykkanen H ^a   El Nezami, H ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH KINETICS; MEDICAL PROBLEMS; MICROBIOLOGY; TOXICITY;

FECAL EXCRETION; GG TREATMENT; INTESTINAL ABSORPTION; LIVER INJURY;

BACTERIA;

AFLATOXIN B1; PROBIOTIC AGENT;

BACTERIUM; EXCRETION; RODENT; TOXICITY; TOXIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FECES; FOOD POISONING; GROWTH DISORDER; INTESTINE ABSORPTION; LACTOBACILLUS RHAMNOSUS; LACTOBACILLUS RHAMNOSUS GG; LIVER INJURY; NONHUMAN; PROTEIN BINDING; RAT; STRAIN IDENTIFICATION;

AFLATOXIN B1; ANIMALS; FECES; INTESTINAL ABSORPTION; LACTOBACILLUS RHAMNOSUS; PROBIOTICS; RATS; RATS, WISTAR; WEIGHT GAIN;

BACTERIA (MICROORGANISMS); LACTOBACILLUS RHAMNOSUS;

EID: 33751015448     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/AEM.01348-06     Document Type: Article

References (20)

1. Anonymous. 1993. IARC monographs on the evaluation of carcinogenic risks to humans: some naturally occurring substances-food items and constituents, heterocyclic aromatic amines and mycotoxins. World Health Organization, Geneva, Switzerland.
2. Chapot, B., and C. P. Wild. 1991. ELISA for quantification of aflatoxin-albumin adducts and their application to human exposure assessment, p. 135-155. In M. Warhol, D. van Velzen, and G. R. Bullock (ed.), Techniques in diagnostic pathology. Academic Press, San Diego, Calif.
3. 1 in rat is a glutathione conjugate. Chem. Biol. Interact. 22:239-255.
4. Ding, X. X., and L. S. Kaminsky. 2003. Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu. Rev. Pharmacol. 43:149-173.
5. Egner, P. A., J. B. Wang, Y. R. Zhu, B. C. Zhang, Y. Wu, Q. N. Zhang, G. S. Qian, S. Y. Kuang, S. J. Gange, L. P. Jacobson, K. J. Helzlsouer, G. S. Bailey, J. D. Groopman, and T. W. Kensler. 2001. Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer. Proc. Natl. Acad. Sci. USA 98:14601-14606.
6. 1. Food Chem. Toxicol. 36:321-326.
7. El-Nezami, H., P. Kankaanpaa, S. Salminen, and J. Ahokas. 1998. Physicochemical alterations enhance the ability of dairy strains of lactic acid bacteria to remove aflatoxin from contaminated media. J. Food Prot. 61:466-468.
8. El-Nezami, H., H. Mykkanen, P. Kankaanpaa, S. Salminen, and J. Ahokas. 2000. Ability of Lactobacillus and Propionibacterium strains to remove aflatoxin B from the chicken duodenum. J. Food Prot. 63:549-552.
9. El-Nezami, H., N. Polychronaki, S. Salminen, and H. Mykkänen. 2002. Binding rather than metabolism may explain the interaction of two food-grade Lactobacillus strains with zearalenone and its derivative α-zearalenol. Appl. Environ. Microbiol. 68:3545-3549.
10. El-Nezami, H. S., A. Chrevatidis, S. Auriola, S. Salminen, and H. Mykkanen. 2002. Removal of common Fusanum toxins in vitro by strains of Lactobacillus and Propionibacterium. Food Addit. Contam. 19:680-686.
11. 1 in vitro. Appl. Environ. Microbiol. 70:6306-6308.
12. Haskard, C., C. Binnion, and J. Ahokas. 2000. Factors affecting the sequestration of aflatoxin by Lactobacillus rhamnosus strain GG. Chem. Biol. Interact. 128:39-49.
13. Hsieh, D., and J. J. Wong. 1994. Pharmacokinetics and excretion of aflatoxins, p. 73-88. In D. L. Eaton and J. Groopman (ed.), The toxicology of aflatoxins: human health, veterinary and agricultural significance. Academic Press, New York, N.Y.
14. IARC. 2002. IARC monographs on the evaluation of carcinogenic risks to humans: some traditional herbal medicines, some mycotoxins, naphthalene and styrene. IARC Monogr. 82:171.
15. Lu, H., and Y. Ll. 2002. Effects of bicyclol on aflatoxin B-1 metabolism and hepatotoxicity in rats. Acta Pharmacol. Sin. 23:942-945.
16. Maxuitenko, Y. Y., W. G. North, and B. D. Roebuck. 1997. Urinary taurine as a non-invasive marker of aflatoxin B-1-induced hepatotoxicity: success and failure. Toxicology 118:159-169.
17. Mykkanen, H., H. L. Zhu, E. Salminen, R. O. Juvonen, W. H. Ling, J. Ma, N. Polychronaki, H. Kemilainen, O. Mykkanen, S. Salminen, and H. El-Nezami. 2005. Fecal and urinary excretion of aflatoxin B-1 metabolites (AFQ(1), AFM(1) and AFB-N-7-guanine) in young Chinese males. Int. J. Cancer 115:879-884.
18. Phillips, T. D., S. L. Lemke, and P. G. Grant. 2002. Characterization of clay-based enterosorbents for the prevention of aflatoxicosis. Adv. Exp. Med. Biol. 504:157-171.
19. Pierides, M., H. El-Nezami, K. Peltonen, S. Salminen, and J. Abekas. 2000. Ability of dairy strains of lactic acid bacteria to bind aflatoxin M1 in a food model. J. Food Prot. 63:645-650.
20. Turner, P. C., A. Sylla, Y. Y. Gong, M. S. Diailo, A. E. Sutcliffe, A. J. Hall, and C. P. Wild. 2005. Reduction in exposure to carcinogenic aflatoxins by postharvest intervention measures in West Africa: a community-based intervention study. Lancet 365:1950-1956.